Key Insights

Highlights

Success Rate

88% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

5.7%

2 terminated out of 35 trials

Success Rate

88.2%

+1.7% vs benchmark

Late-Stage Pipeline

11%

4 trials in Phase 3/4

Results Transparency

27%

4 of 15 completed with results

Key Signals

4 with results88% success

Data Visualizations

Phase Distribution

17Total
Not Applicable (11)
P 1 (1)
P 2 (1)
P 3 (3)
P 4 (1)

Trial Status

Completed15
Unknown10
Recruiting4
Not Yet Recruiting3
Terminated2
Withdrawn1

Trial Success Rate

88.2%

Benchmark: 86.5%

Based on 15 completed trials

Clinical Trials (35)

Showing 20 of 20 trials
NCT07162220Not ApplicableCompleted

The Effect of a Mobile Game Application on Children With CRF

NCT06911645Not ApplicableCompleted

Diagnostic Reasoning With Customized GPT-4 Model

NCT06857526Not Yet RecruitingPrimary

The Relationship of Hand Sensory and Strength Assessments with Functionality and Kinesiophobia in Individuals with Rheumatoid Arthritis

NCT04912856Phase 3Terminated

An Open-Label Extension of the Study XEN496 (Ezogabine) in Children With KCNQ2-DEE

NCT06826014Recruiting

TREC@TAMU Cancer Prevention Registry and Repository

NCT06812091Recruiting

Human Microbiome Research and Development for Overcoming Pediatric Diseases

NCT06081452Recruiting

Public Survey on Breath Testing for Health and Disease

NCT06271538Phase 4Recruiting

Evaluation of Efficacy of Skål Pro Powder on Symptoms of Irritable Bowel Syndrome

NCT06627985Not Yet Recruiting

Multi-Disciplinary Treatment on the Anthropomorphism of Large Language Models

NCT04639310Phase 3Terminated

XEN496 (Ezogabine) in Children With KCNQ2 Developmental and Epileptic Encephalopathy

NCT04210713Phase 1Completed

Neuroimmune Dysfunction in Alcohol Use Disorder

NCT06036433Not ApplicableUnknown

Light Therapy Plus Exercise to Improve Motor, Non-Motor Symptoms and QoL in Parkinson's Disease

NCT05564559Not ApplicableCompletedPrimary

Multifamily Group Psychoeducation for SUD's in Turkey

NCT05930626CompletedPrimary

Biomarkers of Acrylamide, Glycidol, POPs, PFAS and Disease Outcomes and OMICs Signatures

NCT05853991Not ApplicableNot Yet Recruiting

Effects of Touch on Brain Connectivity and Metabolic Biomarkers in Preterm Infants

NCT05214534Completed

Contribution of SuPAR for Patients in a Situation of Uncertainty Downstream of Emergencies

NCT03295123Completed

Outcome of Children Born After Pregnancy Denial

NCT03722459Not ApplicableCompletedPrimary

Novel MRI Sequence- MR Fingerprinting

NCT05608096Unknown

European Registry for Hemadsorption in Sepsis With the Seraph Filter

NCT04774263CompletedPrimary

The Acceptability of a Real-time Localization for Patients and Caregivers

Scroll to load more

Research Network

Activity Timeline